investors
Webcast
Q4 2012 Mazor Robotics Ltd. Earnings Conference Call
Wednesday, 20 March 10am EDT
* For optimal audio , we recommend to use internet explorer browser
Investors
IR Fact Sheet Highlights
Mazor Robotics is dedicated to the development and marketing of innovative, robotic surgical guidance systems and complementary products that provide a safer surgical environment for patients, surgeons, and OR staff.
Renaissance™, Mazor Robotics’ flagship product, is transforming back surgery by advancing surgical techniques from freehand procedures to highly-accurate, state-of-the-art guided procedures. This means better clinical outcomes for patients with less pain, fewer complications, and shorter recovery time. Renaissance™ is in daily use in leading hospitals with thousands of successful cases worldwide.
- Listed on the Tel-Aviv Stock Exchange since 2007 (TASE: MZOR).
- Core technologies and clinical pipeline include surgical robotics, robotic-guided implants, new procedures using these technologies, and medical 3D imaging for surgery.
- Headquartered in Israel, the Company has wholly-owned subsidiaries in the USA and Germany, as well as a growing network of international distributors.
- Mazor Robotics has 60 highly-qualified employees worldwide.
Trading Information
|
Type
|
Name | Symbol |
| Share | MAZOR ROBOTICS | |
| Convertible Bond | MAZOR ROBOT C1 |
New York Times
CORNER OFFICE
by Adam Bryant
Ori Hadomi, the chief executive of Mazor Robotics, a medical technology company based in Israel, says businesses can become too optimistic in their planning, so it's important to have someone on board who can ask critical questions.